Heat shock proteins are therapeutic targets in autoimmune diseases and other chronic inflammatory conditions

Expert Opinion on Therapeutic Targets

Volumn 16, Issue 9, 2012, Pages 849-857

  Keijzer, Chantal ^a   Wieten, Lotte ^a   Van Herwijnen, Martijn ^a   Van Der Zee, Ruurd ^a   Van Eden, Willem ^a   Broere, Femke ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Autoimmunity; Chronic inflammation; Heat shock proteins; Regulatory T cells; Therapy

Indexed keywords

ANTIINFLAMMATORY AGENT; CARVACROL; EPITOPE; ETANERCEPT; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; PEPTIDE B 29; PEPTIDE DIAPEP277; PEPTIDE DNAJP1; PEPTIDE P180-188; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; AGING; ANTIGEN SPECIFICITY; ARTHRITIS; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; EPITOPE MAPPING; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DERMATOMYOSITIS; NONHUMAN; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

AUTOIMMUNE DISEASES; CHRONIC DISEASE; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; T-LYMPHOCYTES, REGULATORY;

EID: 84865316534     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2012.706605     Document Type: Review

References (83)

1. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155(3):1151-64
2. Li S, Zhou Y, Fan J, et al. Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide-induced peritonitis in rats. Am J Pathol 2011;179(6):2822-34
3. Dengjel J, Schoor O, Fischer R, et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci USA 2005;102(22):7922-7 (Pubitemid 40781039)
4. Orenstein SJ, Cuervo AM. Chaperone-mediated autophagy: Molecular mechanisms and physiological relevance. Semin Cell Dev Biol 2010;21(7):719-26
5. Dice JF. Chaperone-mediated autophagy. Autophagy 2007;3(4):295-9 (Pubitemid 46986334)
6. van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005;5(4):318-30 (Pubitemid 40516157)
7. Burkart V, Germaschewski L, Schloot NC, et al. Deficient heat shock protein 70 response to stress in leukocytes at onset of type 1 diabetes. Biochem Biophys Res Commun 2008;369(2):421-5
8. Kurucz I, Morva A, Vaag A, et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 2002;51(4):1102-9 (Pubitemid 34438356)
9. Gutsmann-Conrad A, Pahlavani MA, Heydari AR, Richardson A. Expression of heat shock protein 70 decreases with age in hepatocytes and splenocytes from female rats. Mech Ageing Dev 1999;107(3):255-70 (Pubitemid 29210228)
10. Heydari AR, You S, Takahashi R, et al. Age-related alterations in the activation of heat shock transcription factor 1 in rat hepatocytes. Exp Cell Res 2000;256(1):83-93 (Pubitemid 30211170)
11. Rao DV, Watson K, Jones GL. Age-related attenuation in the expression of the major heat shock proteins in human peripheral lymphocytes. Mech Ageing Dev 1999;107(1):105-18 (Pubitemid 29113077)
12. Njemini R, Lambert M, Demanet C, et al. The induction of heat shock protein 70 in peripheral mononuclear blood cells in elderly patients: a role for inflammatory markers. Hum Immunol 2003;64(6):575-85 (Pubitemid 36706049)
13. Njemini R, Abeele MV, Demanet C, et al. Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J Clin Immunol 2002;22(4):195-205 (Pubitemid 34774983)
14. Singh R, Kølvraa S, Bross P, et al. Reduced heat shock response in human mononuclear cells during aging and its association with polymorphisms in HSP70 genes. Cell Stress Chaperones 2006;11(3):208-15 (Pubitemid 44343757)
15. Broere F, Wieten L, Klein Koerkamp EI, et al. Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes. J Immunol 2008;181(2):899-906
16. Wieten L, Berlo SE, Ten Brink CB, et al. IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis. PLoS One 2009;4(1):e4186
17. Glant TT, Finnegan A, Mikecz K. Proteoglycan-induced arthritis: Immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol 2003;23(3):199-250 (Pubitemid 37204432)
18. Glant TT, Mikecz K. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis. Methods Mol Med 2004;102:313-38
19. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice. clinical features and histopathology. Arthritis Rheum 1987;30(2):201-12 (Pubitemid 17060776)
20. Van Eden W, Anderton SM, Van Der Zee R, et al. (Altered) self peptides and the regulation of self reactivity in the peripheral T cell pool. Immunol Rev 1996;149:55-73 (Pubitemid 26096978)
21. Anderton SM, van der Zee R, Prakken B, et al. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med 1995;181(3):943-52
22. Anderton SM, van der Zee R, Noordzij A, van Eden W. Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J Immunol 1994;152(7):3656-64 (Pubitemid 24098064)
23. Wauben MH, Boog CJ, van der Zee R, et al. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone. J Exp Med 1992;176(3):667-77
24. Prakken BJ, van der Zee R, Anderton SM, et al. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci USA 1997;94(7):3284-9
25. Kamphuis S, Kuis W, de Jager W, et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 2005;366(9479):50-6 (Pubitemid 40956530)
26. de Kleer IM, Kamphuis SM, Rijkers GT, et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 2003;48(7):2001-10 (Pubitemid 36828695)
27. de Graeff-Meeder ER, van Eden W, Rijkers GT, et al. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest 1995;95(3):934-40
28. Elst EF, Klein M, de Jager W, et al. Hsp60 in inflamed muscle tissue is the target of regulatory autoreactive T cells in patients with juvenile dermatomyositis. Arthritis Rheum 2008;58(2):547-55 (Pubitemid 351294889)
29. Albani S, Keystone EC, Nelson JL, et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1995;1(5):448-52
30. Koffeman EC, Genovese M, Amox D, et al. Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. Arthritis Rheum 2009;60(11):3207-16
31. Prakken BJ, Samodal R, Le TD, et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci USA 2004;101(12):4228-33 (Pubitemid 38405911)
32. Raz I, Elias D, Avron A, et al. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001;358(9295):1749-53 (Pubitemid 33152998)
33. Raz I, Avron A, Tamir M, et al. Treatment of new-onset type 1 diabetes with peptide DiaPep277® is safe and associated with preserved beta-cell function: Extension of a randomized, double-blind, phase II trial. Diabetes Metab Res Rev 2007;23(4):292-8 (Pubitemid 46851470)
34. Chen W, Syldath U, Bellmann K, et al. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 1999;162(6):3212-19 (Pubitemid 29313567)
35. Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc Biol 2009;85(6):905-10
36. Aldridge S. Toll-like receptor blocker slows beta cell death in type 1 diabetes. Nat Biotechnol 2012;30(2):124-124c
37. Van Puijvelde GHM, Van Es T, Van Wanrooij EJA, et al. Induction of oral tolerance to HSP60 or an HSP60-peptide activates t cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27(12):2677-83 (Pubitemid 350158922)
38. Jorgensen C, Gedon E, Jaquet C, Sany J. Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice. J Rheumatol 1998;25(4):763-7 (Pubitemid 28212388)
39. Cobelens PM, Heijnen CJ, Nieuwenhuis EES, et al. Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp65 during disease. Arthritis Rheum 2000;43(12):2694-702 (Pubitemid 32001735)
40. Wendling U, Paul L, van der Zee R, et al. A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol 2000;164(5):2711-17 (Pubitemid 30115504)
41. Mayer L, Shao L. Therapeutic potential of oral tolerance. Nat Rev Immunol 2004;4(6):407-19 (Pubitemid 38745553)
42. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005;206:232-59 (Pubitemid 41105174)
43. Hou Y, Hu WG, Hirano T, Gu XX. A new intra-NALT route elicits mucosal and systemic immunity against moraxella catarrhalis in a mouse challenge model. Vaccine 2002;20(17-18):2375-81 (Pubitemid 34497049)
44. Petrarca C, Lazzarin F, Pannellini T, et al. Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. Int J Immunopathol Pharmacol 2010;23(4):1021-31
45. Langley JM, Aoki F, Ward BJ, et al. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness. Vaccine 2011;29(10):1921-8
46. Davis SS. Nasal vaccines. Adv Drug Deliv Rev 2001;51(1-3):21-42 (Pubitemid 32763070)
47. Isaka M, Zhao Y, Nobusawa E, et al. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice. Microbiol Immunol 2008;52(2):55-63
48. Phipps PA, Stanford MR, Sun JB, et al. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur J Immunol 2003;33(1):224-32 (Pubitemid 36157660)
49. Slutter B, Plapied L, Fievez V, et al. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J Control Release 2009;138(2):113-21
50. Slutter B, Bal S, Keijzer C, et al. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen. Vaccine 2010;28(38):6282-91
51. Csaba N, Garcia-Fuentes M, Alonso MJ. Nanoparticles for nasal vaccination. Adv Drug Deliv Rev 2009;61(2):140-57
52. Dobrovolskaia MA, Germolec DR, Weaver JL. Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol 2009;4(7):411-14
53. Keijzer C, Slutter B, van der Zee R, et al. PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity. PLoS One 2011;6(11):e26684
54. Morimoto RI. Regulation of the heat shock transcriptional response: Cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 1998;12(24):3788-96 (Pubitemid 29024840)
55. Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science 1993;259(5100):1409-10 (Pubitemid 23101373)
56. Liu AY, Choi HS, Lee YK, Chen KY. Molecular events involved in transcriptional activation of heat shock genes become progressively refractory to heat stimulation during aging of human diploid fibroblasts. J Cell Physiol 1991;149(3):560-6 (Pubitemid 21910225)
57. Jurivich DA, Qiu L, Welk JF. Attenuated stress responses in young and old human lymphocytes. Mech Ageing Dev 1997;94(1-3):233-49 (Pubitemid 27216111)
58. Shamovsky I, Gershon D. Novel regulatory factors of HSF-1 activation: Facts and perspectives regarding their involvement in the age-associated attenuation of the heat shock response. Mech Ageing Dev 2004;125(10-11 SPEC. ISS):767-75 (Pubitemid 39482405)
59. Arvonen M, Tikanmaki M, Vahasalo P, Karttunen TJ. Heat shock protein expression is low in intestinal mucosa in juvenile idiopathic arthritis: a defect in immunoregulation? Scand J Rheumatol 2010;39(3):212-18
60. Westerheide SD, Morimoto RI. Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem 2005;280(39):33097-100 (Pubitemid 41397104)
61. Soti C, Csermely P. Pharmacological modulation of the heat shock response. Handb Exp Pharmacol 2006(172):417-36
62. Morimoto RI, Santoro MG. Stress-inducible responses and heat shock proteins: New pharmacologic targets for cytoprotection. Nat Biotechnol 1998;16(9):833-8 (Pubitemid 28405852)
63. Wieten L, Broere F, van der Zee R, et al. Cell stress induced HSP are targets of regulatory T cells: a role for HSP inducing compounds as anti-inflammatory immuno-modulators? FEBS Lett 2007;581(19):3716-22 (Pubitemid 47081007)
64. Kiang JG. Genistein inhibits herbimycin A-induced over-expression of inducible heat shock protein 70 kDa. Mol Cell Biochem 2003;245(1-2):191-9 (Pubitemid 36416836)
65. Wieten L, van der Zee R, Spiering R, et al. A novel HSP co-inducer boosts stress protein HSP70 to activate T cell regulation of inflammation in autoimmune arthritis. Arthritis Rheum 2010;62(4):1026-35
66. Skoula M, Gotsiou P, Naxakis G, Johnson CB. A chemosystematic investigation on the mono-and sesquiterpenoids in the genus origanum (labiatae). Phytochemistry 1999;52(4):649-57 (Pubitemid 29518677)
67. Burt S. Essential oils: their antibacterial properties and potential applications in foods-a review. Int J Food Microbiol 2004;94(3):223-53 (Pubitemid 38891349)
68. Burt SA, Van Der Zee R, Koets AP, et al. Carvacrol induces heat shock protein 60 and inhibits synthesis of flagellin in escherichia coli O157:H7. Appl Environ Microbiol 2007;73(14):4484-90 (Pubitemid 47122592)
69. Kato K, Ito H, Kamei K, Iwamoto I. Stimulation of the stress-induced expression of stress proteins by curcumin in cultured cells and in rat tissues in vivo. Cell Stress Chaperones 1998;3(3):152-60 (Pubitemid 28434679)
70. Funk JL, Oyarzo JN, Frye JB, et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod 2006;69(3):351-5
71. Lee KW, Kim JH, Lee HJ, Surh YJ. Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 2005;7(11-12):1612-20 (Pubitemid 41767996)
72. De Graeff-Meeder ER, van der Zee R, Rijkers GT, et al. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 1991;337(8754):1368-72
73. Brusko TM, Putnam AL, Bluestone JA. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 2008;223(1):371-90 (Pubitemid 351986182)
74. Valencia X, Stephens G, Goldbach-Mansky R, et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006;108(1):253-61 (Pubitemid 43990636)
75. Peluso I, Fantini MC, Fina D, et al. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 2007;178(2):732-9 (Pubitemid 46095145)
76. Horwitz DA, Zheng SG, Gray JD. Natural and TGF-beta-induced Foxp3 +CD4+ CD25+ regulatory T cells are not mirror images of each other. Trends Immunol 2008;29(9):429-35
77. Asquith DL, McInnes IB. Emerging cytokine targets in rheumatoid arthritis. Curr Opin Rheumatol 2007;19(3):246-51 (Pubitemid 46597461)
78. Genovese MC, Becker J-, Schiff M, et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med 2005;353(11):1114-23 (Pubitemid 41317434)
79. Tsokos GC. B cells, be gone-B-cell depletion in the treatment of rheumatoid arthritis. N Engl J Med 2004;350(25):2546-8 (Pubitemid 38758541)
80. Prohaszka Z, Fust G. Immunological aspects of heat-shock proteins-the optimum stress of life. Mol Immunol 2004;41(1):29-44 (Pubitemid 38609394)
81. Roord ST, Zonneveld-Huijssoon E, Le T, et al. Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis. PLoS One 2006;1:e87
82. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4 +CD25+FoxP3+ regulatory T cells. Blood 2005;105(12):4743-8
83. van Eden W, Lisse J, Prakken B, Albani S. Biologics and postbiologics: Novel immunotherapeutics for the induction and maintenance of remission. Drug Discov Today 2010;15(1-2):71-7